Dermatologicals in Georgia
DERMATOLOGICALS IN GEORGIA
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Hair Loss Treatments and Medicated Shampoos Remain Small With Growth Potential
Stigma Supports the Growth of Haemorrhoid Treatments
Change in Distribution Channels Set To Support Growth of Smaller Categories
Competitive Landscape
Local Production Plays Important Role in Dermatologicals in Georgia
Leading Gbo Stada Arzneimittel AG Conditioned by Wide Product Portfolio
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023
Executive Summary
Changes in Consumer Lifestyle Drive Growth of Consumer Health
Relative Stabilisation of Georgian Currency Brings Strong Value Growth
Local Manufacturers Slowly But Steadily Manage To Expand Sales Share
Emerging Areas of Consumer Health Support Variety of Distribution Channels
Consumer Health Is Expected To Maintain Positive Growth
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018
Market Data
Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Distribution of Consumer Health by Format: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format and Category: % Value 2018
Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources
Within dermatologicals in Georgia, the two areas of hair loss treatments and medicated shampoos were not regarded as essential products. Poor disposable incomes, availability, choice and awareness led to low demand. Medicated shampoos also faced strong competition from hair salons. A major part of sales still went through hair salons as demand to purchase such products in retail remained low. However, in the forecast period, with growing disposable incomes, strong promotions could increase retai...
Euromonitor International's Dermatologicals in Georgia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.